Director of Early Pipeline & Corporate Strategy - Remote

Overview

The Director of Early Pipeline & Corporate Strategy plays a pivotal role in shaping the strategic direction of our Immunology Innovation Program (IIP) and aligning early R&D initiatives with broader corporate objectives.

In Short

• Build business cases for early IIP opportunities across immunology indications.
• Provide strategic input into discovery-stage efforts and target prioritization.
• Integrate IIP portfolio insights into long-range planning and development roadmaps.
• Develop frameworks to assess translational and commercial potential of early-stage assets.
• Track competitive landscape and scientific trends to inform early investment decisions.
• Support portfolio reviews and cross-functional prioritization.
• Conduct scenario planning and risk/benefit analysis to inform pipeline decisions.
• Contribute to the company’s strategic planning and long-term corporate vision.
• Lead valuation and forecasting models across therapeutic areas.
• Collaborate with commercial and HEOR teams to understand unmet need and opportunity spaces.

Requirements

• 8–12+ years of experience in biotech/pharma strategy, strategic finance, corporate development, or consulting.
• Advanced degree in life sciences or an MBA with strong scientific fluency (Immunology background preferred).
• Experience working with early-stage pipelines and scientific uncertainty.
• Strong analytical and modeling capabilities with the ability to distill complex inputs into clear recommendations.
• Strategic thinker with excellent communication and influencing skills.
• Comfortable operating in a dynamic, cross-functional, and global environment.
• Proven ability to lead through influence and foster collaboration across diverse teams.

Benefits

• Competitive compensation and benefits
• A flexible, inclusive work environment
• A values-based culture focused on innovation, integrity, and impact